Bafna Pharmaceuticals Ltd - BAFNAPH: Balance Sheet, Financial Statements

Bafna Pharmaceuticals Ltd Balance Sheet

Switch to

Switch to

Y/e 31 Mar ( In .Cr)	Mar-2020	Mar-2019	Mar-2018	Mar-2017
Equity capital	57.70	23.70	23.70	22.70
Preference capital	--	--	--	--
Reserves	(6.60)	(4.60)	14.30	20
Net worth	51.10	19.10	37.90	42.70
Minority interest
Debt	3.02	46.20	46.50	82.40
Deferred tax liabilities (net)	--	6.18	5.11	2.92
Total liabilities	54.20	71.30	88.90	127
Fixed assets	35.20	37.10	44.90	48.60
Intangible assets
Investments	--	--	--	16.90
Deferred tax asset (net)	--	--	--	--
Net working capital	10.50	31.50	41	59.30
Inventories	11.40	9.28	10.70	16.70
Inventory Days	98.10	78.10	82.60	94.10
Sundry debtors	6.03	24.80	24.30	53.80
Debtor days	51.80	209	188	302
Other current assets	10.20	45.60	55.60	39.60
Sundry creditors	(13)	(40)	(29)	(24)
Creditor days	108	333	221	134
Other current liabilities	(4.60)	(8.70)	(21)	(27)
Cash	8.48	2.71	2.95	2.66
Total assets	54.20	71.30	88.90	127